Sub-Tap Direct Selling: Network Marketing Myths for Driving Communications and Information Technologies as the Company Continues International Expansion
San Diego, California – (NewMediaWire ) – November 29, 2022 – Medical Marijuana, Inc. (OTC: MJNA) (“the Company”), the first publicly traded drug company in the United States that launched the world’s first hemp-derived nutritional products, brands, and supply chain, today announced that its Kannaway subsidiary has appointed two industry veterans to the leadership roles within the organization; Mike Randolph, Executive Vice President, and Mike Kolinsky, Vice President, Information Technology.
Mr. Randolph is a 31-year industry veteran who brings a combination of an entrepreneurial spirit and a diverse professional background to Canawy. He will oversee internal and external communications, customer service, and compliance for Kannaway.
“Even if you knew what you were looking for, you could search your entire life and not find a company like Kannaway, with outstanding founders, a captivating story, and outstanding corporate and field leadership teams,” said newly appointed Executive Vice President Mike Mike. Randolph.
Newly appointed Vice President of Information Technology Mike Kolinsky brings 25 years of industry experience, working in both sales and customer support roles, before taking on a leadership role in IT where he was Vice President for nearly two decades. Mr. Kolinsky oversaw systems for large organizations and will be tasked with managing all of Kannaway’s web infrastructure and back office, with a focus on sales and commission systems.
“Expanding a cannabis company around the world can be complex. For this reason, the number one value in our company is clarity. I am confident that both Mr. Randolph and Mr. Kolinsky will assist us in our efforts to simplify and clarify our efforts and our mission as we press to drive positive global change “.
About Medical Marijuana, Inc.
We are Al Awael Company (R). Medical marijuana, Inc. ( MJNA ) is a cannabis company with three distinct business units in the non-psychoactive cannabis space: a global group of hemp-based nutritional brands led by Kanawee (R) And hemp; leader in sourcing high quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the cannabis-based clinical research and plant-based drug development segment led by pharmaceutical investment firms and their partners incl AXIM(R) Biotechnologies, Inc. And Neurobatics. Medical Marijuana, Inc. As the best CBD product by CNBC. Medical Marijuana, Inc. Also the first company to obtain historical import authorizations for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in the development of international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. Watch the Medical Marijuana, Inc. video. , click here.
About Kanawee
As a proud member of the U.S. Hemp Commission, Kannaway manufactures and markets some of the world’s most innovative wellness products sourced from the hemp plant, one of the oldest natural resources on Earth. With countless practical uses, including wellness, nutrition, textiles, and renewable building materials, Kannaway’s goal is to re-establish hemp as an essential part of global commerce and agriculture. With this goal in mind, Kannaway continues as a leader in providing cannabidiol (CBD) products legally throughout the United States and to over thirty other countries around the world, following the strictest GMP practices and producing some of the highest quality products found anywhere in the world. . Kannaway is now one of the largest and fastest growing cannabis cultivation companies in the world.
Forward-looking Disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, and is subject to the safe harbor laws established by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and are subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ. materially from the data presented here.
Disclosure to the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, cure, or prevent any disease.
Legal disclosure
Medical Marijuana, Inc. does not sell or distribute any products that violate the US Controlled Substances Act.
Contact:
PR contact:
Kyle Porter
CEO
CMW Media
pp. 858-221-8001
Investor Relations Contact:
P. (858) 283-4016
View the original version at www.newmediawire.com
*****
Are you looking for marijuana business guides and books about cannabis? Then you should not miss our online bookstore with hundreds of books about cannabis, CBD, THC and more!
*******
